Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
- PMID: 29770622
- PMCID: PMC5981103
- DOI: 10.3802/jgo.2018.29.e51
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. N Engl J Med. 2018. PMID: 29342393 Clinical Trial.
References
-
- van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HW, Hermans RH, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230–240. - PubMed
-
- Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22:1570–1575. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
